Return the favour: South Korea looks to U.S. for COVID-19 vaccine aid

South Korea hopes the United States will help it tackle a shortage of coronavirus vaccine in return for test kits and masks Seoul sent to Washington earlier in the pandemic, the foreign minister said on Wednesday.

The government has drawn fire from the media for not doing enough to secure enough vaccines early, with just 3% of the population inoculated, due to tight global supply and limited access.

“We have been stressing to the United States that ‘A friend in need is a friend indeed,'” the minister, Chung Eui-yong, told reporters at the Kwanhun Club of South Korean journalists.

He said South Korea had airlifted Washington a large volume of coronavirus test kits and face masks in the early stages of the pandemic “in the spirit of the special South Korea-U.S. alliance,” despite tight domestic supply at the time.

“We are hoping that the United States will help us out with the challenges we are facing with the vaccines, based on the solidarity we demonstrated last year.”

The allies were in talks, added Chung, who also flagged South Korea’s potential contribution to preserving a global semiconductor supply chain U.S. President Joe Biden is keen to maintain.

Diplomatic efforts have not yielded any concrete steps, however, as the talks with Washington are still in an early stage, health ministry official Son Young-rae told reporters.

Opposition lawmaker Park Jin urged more aggressive vaccine diplomacy, calling for the government to invoke its free trade pact (FTA) with Washington to secure pharmaceutical products.

“The government needs to be more proactive,” Park told Reuters.

“The FTA provides us a legal base to demand (vaccines) as it stipulates the two countries’ commitment to promoting the development of, and facilitating access to, pharmaceutical products.”

The U.S. embassy in Seoul did not immediately reply to a Reuters’ request for comment.

About 1.77 million people in South Korea have had their first dose of the AstraZeneca Plc (AZN.L) or Pfizer (PFE.N) vaccines. The low rate compares with a 40% vaccination rate in the United States, according to Reuters data.

Tuesday’s 731 new coronavirus infections, up from 549 cases a day earlier, took South Korea’s tally to 115,926, with 1,806 deaths.

(Global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)

Our Standards: The Thomson Reuters Trust Principles.

Source: https://www.reuters.com/world/asia-pacific/return-favour-south-korea-looks-us-covid-19-vaccine-aid-2021-04-21/

World Economic Magazine

Recent Posts

Morgan Stanley Agrees to Buy Vinyl Equity for Shareholder Services

The pending acquisition would add transfer-agent and ownership-record capabilities to Morgan Stanley at Work; the…

9 hours ago

Goodyear Installs Roger Wood as Interim CEO During Strategic Review

Mark Stewart exits immediately as the board continues examining the company’s business mix, footprint and…

1 day ago

Securitize Seeks a Lending Foothold With River One Acquisition

The pending deal would connect asset-backed financing with its tokenization business, but market-size figures do…

2 days ago

LKQ Accelerates Sal Abbate’s Arrival as Chief Executive

The automotive-parts supplier ends its interim leadership arrangement more than a month ahead of the…

2 days ago

U.S. and 14 Partners Set Agenda on Manufacturing Excess Capacity

A joint ministerial statement calls for sectoral discussions and an end to market-distorting policies, without…

3 days ago

Aruba Signs Battery Deal to Coordinate Its Power System

Wärtsilä’s 35-megawatt storage project pairs batteries with energy management and maintenance, with takeover expected in…

4 days ago